Abstract
Autologous tissues including dermis and fat have long been used for soft tissue augmentation to correct facial wrinkles or skin contour defects. Additionally, given the advances in molecular biology and tissue engineering, soft tissue filler products are widely used. However, their variable degrees of resorption require repeated injections. To overcome these drawbacks, the author created a new injectable filler consisting of a mixture of hyaluronic acid filler and living autologous cells. In this chapter, the author’s basic research and clinical experiences with the tissue-engineered injectable soft tissue using cultured dermal fibroblasts, adipose-derived stromal vascular fraction cells and adipose-derived in vitro-differentiated adipocytes are presented. The injection of tissue-engineered soft tissue has many advantages. It is a simple procedure and can be carried out at an office without entering the operation room. Moreover, it almost eliminates communication errors between the physician and patient, because patients can immediately assess the results. In addition, patients feel more comfortable because autologous tissue is used.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Alster TS, West TB. Human-derived and new synthetic injectable materials for soft-tissue augmentation: current status and role in cosmetic surgery. Plast Reconstr Surg. 2000;105:2515–25.
Ashjian PH, De Ugarte DA, Katz AJ, et al. Lipoplasty: from body contouring to tissue engineering. Aesthet Surg. 2002;22:121–7.
Austin H, Weston G. Rejuvenation of the aging mouth. Clin Plast Surg. 1992;19:511–24.
Boss WK, Usal H, Chernoff G, et al. Autologous cultured fibroblasts as cellular therapy in plastic surgery. Clin Plast Surg. 2000;27:613–26.
Botti G, Villedieu R. Augmentation cheiloplasty by using mucomuscular flaps. Aesthetic Plast Surg. 1995;19:69–74.
Brown MB, Jones SA. Hyaluronic acid. A unique topical vehicle for the localized delivery of drugs in the skin. J Eur Acad Dermatol Venerol. 2005;19:308–18.
Burres SA. Recollagenation of acne scars. Dermatol Surg. 1996;22:364–7.
Cho SW, Kim I, Kim SH, et al. Enhancement of adipose tissue formation by implantation of adipogenic-differentiated preadipocytes. Biochem Biophys Res Commun. 2006;345:588–94.
Choi YS, Cha SM, Lee YY, et al. Adipogenic differentiation of adipose tissue derived adult stem cells in nude mouse. Biochem Biophys Res Commun. 2006;345:631–7.
Coleman SR. Long-term survival of fat transplant: controlled demonstrations. Aesthetic Plast Surg. 1995;19:421–5.
Coleman SR. Structural fat grafts: the ideal filler? Clin Plast Surg. 2001;28:111–9.
Davidson BA. Lip augmentation using the palmaris longus tendon. Plast Reconstr Surg. 1995;95:1108–10.
DeVore DP, Hughes E, Scott JB. Effectiveness of injectable filler materials for smoothing wrinkle lines and depressed scars. Med Prog Technol. 1994;20:243–50.
Dragoo JL, Choi JY, Lieberman JR, et al. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res. 2003;21:622–9.
Duranti F, Salti G, Bovani B, et al. Injectable hyaluronic acid gel for soft tissue augmentation: a clinical and histologic study. Dermatol Surg. 1998;24:1317–25.
Elson ML. Soft tissue augmentation. A review. Dermatol Surg. 1995;21:491–500.
Eppley BL, Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg. 2006;118:98–106.
Ersek RA, Beisang III AA. Bioplatique: a new textured copolymer microparticle promises performance in soft-tissue augmentation. Plast Reconstr Surg. 1991;87:693–702.
Fagien S. Autologous collagen injections to treat deep glabellar furrows. Plast Reconstr Surg. 1994;93:642.
Garfein ES, Orgill DP, Pribaz JJ. Clinical applications of tissue engineered constructs. Clin Plast Surg. 2003;30:485–98.
Gatti JE. Permanent lip augmentation with serial fat grafting. Ann Plast Surg. 1999;42:376–80.
Glatz FR, Kalkanis J, Neumeister M, et al. Volume analysis of preadipocyte injection for vocal cord medialization. Laryngoscope. 2003;113:1113–7.
Gold MH. The Fibrel mechanism of action study: a preliminary report. J Dermatol Surg Oncol. 1994;20:586–90.
Han SK, You HJ. Wound coverage using advanced technology in Korea. J Korean Med Assoc. 2011;54:594–603.
Han SK, Shin SH, Kang HJ, Kim WK. Augmentation rhinoplasty using injectable tissue-engineered soft tissue: a pilot study. Ann Plast Surg. 2006;56:251–5.
Hemmrich K, von Heimburg D, Cierpka K, et al. Optimization of the differentiation of human preadipocytes in vitro. Differentiation. 2005;73:28–35.
Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials. 2000;21:2529–43.
Isenberg JS. Further clinical experience in permanent lip augmentation using autologous breast implant capsules. Ann Plast Surg. 1998;40:265–7.
Katz AJ, Llull R, Hedrick MH, et al. Emerging approaches to the tissue engineering of fat. Clin Plast Surg. 1999;26:587–603.
Knapp TR, Kaplan EN, Daniels JR. Injectable collagen for soft tissue augmentation. Plast Reconstr Surg. 1977;60:398–405.
Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–6.
Larsen NE, Pollack CT, Reiner K, et al. Hylan gel biomaterial: dermal and immunologic compatibility. J Biomed Mater Res. 1993;27:1129–34.
Lee H, Park TG. Photo-crosslinkable, biomimetic, and thermo-sensitive pluronic grafted hyaluronic acid copolymers for injectable delivery of chondrocytes. J Biomed Mater Res A. 2009;88:797–806.
Masuda T, Furue M, Matsuda T. Novel strategy for soft tissue augmentation based on transplantation of fragmented omentum and preadipocytes. Tissue Eng. 2004;10:1672–83.
Matsumoto D, Sato K, Gonda K, et al. Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng. 2006;12:3375–82.
Millikan L. Long-term safety and efficiency with Fibrel in the treatment of cutaneous scars: results of a multicenter study. J Dermatol Surg Oncol. 1989;15:837–42.
Mitchell JB, McIntosh K, Zvonic S, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells. 2006;24:376–85.
Mizuno H, Itoi Y, Kawahara S, et al. In vivo adipose tissue regeneration by adipose-derived stromal cells isolated from GFP transgenic mice. Cells Tissues Organs. 2008;187:177–85.
Moseley TA, Zhu M, Hedrick MH. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg. 2006;118:121–8.
Noël D, Caton D, Roche S, et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res. 2008;314:1575–84.
Nunery WR, Hetzler KJ. Dermal fat graft as a primary enucleation technique. Ophthalmology. 1985;92:1256–61.
Richter W. Nonimmunogenicity of purified hyaluronic acid preparations tested by passive cutaneous anaphylaxis. Int Arch Allergy Immunol. 1974;47:211–7.
Richter W, Ryde E, Zetterstrom EO. Nonimmunogenicity of purified sodium hyaluronate preparation in man. Int Arch Allergy Immunol. 1979;59:45–8.
Schäffler A, Büchler C. Concise review: adipose tissue-derived stromal cells – basic and clinical implications for novel cell-based therapies. Stem Cells. 2007;25:818–27.
Schoeller T, Lille S, Wechselberger G, et al. Histomorphologic and volumetric analysis of implanted autologous preadipocyte cultures suspended in fibrin glue: a potential new source for tissue augmentation. Aesthetic Plast Surg. 2001;25:57–63.
Spira M, Rosen T. Injectable soft tissue substitutes. Clin Plast Surg. 1993;20:181–8.
Stegman SJ, Chu S, Bensch K, et al. A light and electron microscopic evaluation of Zyderm collagen and Zyplast implants in aging human facial skin: a pilot study. Arch Dermatol. 1987;123:1644–9.
Suga H, Matsumoto D, Inoue K, et al. Numerical measurement of viable and nonviable adipocytes and other cellular components in aspirated fat tissue. Plast Reconstr Surg. 2008;122:103–14.
Torio-Padron N, Baerlecken N, Momeni A, et al. Engineering of adipose tissue by injection of human preadipocytes in fibrin. Aesthetic Plast Surg. 2007;31:285–93.
Tsugi W, Inamoto T, Yamashiro H, et al. Adipogenesis induced by human adipose tissue-derived stem cells. Tissue Eng Part A. 2009;15:83–93.
Von Heimburg D, Hemmrich K, Zachariah S, et al. Oxygen consumption in undifferentiated versus differentiated adipogenic mesenchymal precursor cells. Respir Physiol Neurobiol. 2005;146:107–16.
Wechselberger G, Russell RC, Neumeister MW, et al. Successful transplantation of three tissue engineered cell types using capsule induction technique and fibrin glue as a delivery vehicle. Plast Reconstr Surg. 2002;110:123–9.
West TB, Alster TS. Autologous human collagen and dermal fibroblasts for soft-tissue augmentation. Dermatol Surg. 1998;24:510–2.
Yoo G, Lim JS. Tissue engineering of injectable soft tissue filler: using adipose stem cells and micronized acellular dermal matrix. J Korean Med Sci. 2009;24:104–9.
Yoon ES, Han SK, Kim WK. Advantages of the presence of living dermal fibroblasts within restylane for soft tissue augmentation. Ann Plast Surg. 2003;51:587–92.
Zuk PA, Zhu M, Ashjian PH, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279–95.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Han, SK. (2016). Injectable Tissue-Engineered Soft Tissue. In: Innovations and Advances in Wound Healing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46587-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-46587-5_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46586-8
Online ISBN: 978-3-662-46587-5
eBook Packages: MedicineMedicine (R0)